Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Dayra Therapeutics manufactures peptide based medicines.
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.
Borealis Biosciences is a company in the field of next-generation RNA medicines.
Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
SixPeaks Bio is developing a pipeline of medicines for healthy weight loss.
ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
A UK-based developer of drugs to treat respiratory diseases
Halio is developing adaptive, dynamic glass for the commercial, residential, and automotive markets.
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Versant Ventures has invested in 89 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Versant Ventures's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 23 different industry categories.
Among tracked funding rounds, CRISPR Therapeutics received $550.0M in a Post-IPO Debt round. Versant Ventures's total known invested capital is $6.1B.
Versant Ventures's average investment size is $68.2M across its portfolio of 89 companies.
Recent Versant Ventures portfolio additions include Nouscom, Tempest Therapeutics, CRISPR Therapeutics, Monte Rosa Therapeutics, Contineum Therapeutics. These companies were founded in 2020 or later.